These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 22388624)

  • 1. Radiopharmaceutical development of radiolabelled peptides.
    Fani M; Maecke HR
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S11-30. PubMed ID: 22388624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiopeptide imaging and therapy in Europe.
    Ambrosini V; Fani M; Fanti S; Forrer F; Maecke HR
    J Nucl Med; 2011 Dec; 52 Suppl 2():42S-55S. PubMed ID: 22144555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status and perspectives in peptide receptor radiation therapy.
    Ansquer C; Kraeber-Bodéré F; Chatal JF
    Curr Pharm Des; 2009; 15(21):2453-62. PubMed ID: 19601842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy.
    de Visser M; Verwijnen SM; de Jong M
    Cancer Biother Radiopharm; 2008 Apr; 23(2):137-57. PubMed ID: 18454684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for the use of radiolabelled peptides in diagnosis and therapy.
    Koopmans KP; Glaudemans AW
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S4-10. PubMed ID: 22388630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical and clinical studies of peptide receptor radionuclide therapy.
    Pool SE; Krenning EP; Koning GA; van Eijck CH; Teunissen JJ; Kam B; Valkema R; Kwekkeboom DJ; de Jong M
    Semin Nucl Med; 2010 May; 40(3):209-18. PubMed ID: 20350630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases.
    Sosabowsky J; Melendez-Alafort L; Mather S
    Q J Nucl Med; 2003 Dec; 47(4):223-37. PubMed ID: 14973415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor targeting with
    Rezazadeh F; Sadeghzadeh N
    Chem Biol Drug Des; 2019 Mar; 93(3):205-221. PubMed ID: 30299570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiolabelled peptides for oncological diagnosis.
    Laverman P; Sosabowski JK; Boerman OC; Oyen WJ
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1(Suppl 1):S78-92. PubMed ID: 22388627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-mediated tumor targeting with radiolabeled peptides: there is more to it than somatostatin analogs.
    Mariani G; Erba PA; Signore A
    J Nucl Med; 2006 Dec; 47(12):1904-7. PubMed ID: 17138731
    [No Abstract]   [Full Text] [Related]  

  • 11. Peptide-based probes for cancer imaging.
    Reubi JC; Maecke HR
    J Nucl Med; 2008 Nov; 49(11):1735-8. PubMed ID: 18927341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabeled regulatory peptides for imaging and therapy.
    Nanda PK; Lane SR; Retzloff LB; Pandey US; Smith CJ
    Curr Opin Endocrinol Diabetes Obes; 2010 Feb; 17(1):69-76. PubMed ID: 19901831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeled peptides in the diagnosis and therapy of oncological diseases.
    Weiner RE; Thakur ML
    Appl Radiat Isot; 2002 Nov; 57(5):749-63. PubMed ID: 12433051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabeled peptides in oncology: role in diagnosis and treatment.
    Weiner RE; Thakur ML
    BioDrugs; 2005; 19(3):145-63. PubMed ID: 15984900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of Different Spacers on Biological Profile of Peptide Radiopharmaceuticals for Diagnosis and Therapy of Human Cancers.
    Farahani AM; Maleki F; Sadeghzadeh N
    Anticancer Agents Med Chem; 2020; 20(4):402-416. PubMed ID: 31889492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-based radiopharmaceuticals for targeted tumor therapy.
    Dong C; Liu Z; Wang F
    Curr Med Chem; 2014; 21(1):139-52. PubMed ID: 23992337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor imaging and therapy using radiolabeled somatostatin analogues.
    de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
    Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of peptide and protein based radiopharmaceuticals.
    Wynendaele E; Bracke N; Stalmans S; De Spiegeleer B
    Curr Pharm Des; 2014; 20(14):2250-67. PubMed ID: 24025103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
    Abiraj K; Mansi R; Tamma ML; Forrer F; Cescato R; Reubi JC; Akyel KG; Maecke HR
    Chemistry; 2010 Feb; 16(7):2115-24. PubMed ID: 20066690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer.
    Okarvi SM
    Cancer Treat Rev; 2008 Feb; 34(1):13-26. PubMed ID: 17870245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.